Please use this identifier to cite or link to this item: http://192.168.1.35:80/jspui/handle/Hannan/31292
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDoherty, AP-
dc.contributor.authorBower, M-
dc.contributor.authorSmith, GL-
dc.contributor.authorMiano, R-
dc.contributor.authorMannion, EM-
dc.contributor.authorMitchell, H-
dc.contributor.authorChristmas, TJ-
dc.date2000-11-14-
dc.date2016-07-29T14:00:37Z-
dc.date2000-11-14-
dc.date2000-08-09-
dc.date.accessioned2019-05-15T09:50:32Z-
dc.date.available2019-05-15T09:50:32Z-
dc.date.issued2016-07-29T14:00:37Z-
dc.identifier1532-1827-
dc.identifierhttp://dx.doi.org/10.1054/bjoc.2000.1474-
dc.identifier.urihttp://localhost/handle/Hannan/31292-
dc.identifier.urihttps://spiral.imperial.ac.uk:8443/handle/10044/1/38377-
dc.languageEnglish-
dc.publisherCancer Research UK-
dc.relationBritish Journal of Cancer-
dc.rightsThis work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/-
dc.source1436-
dc.source1432-
dc.subjectScience & Technology-
dc.subjectLife Sciences & Biomedicine-
dc.subjectOncology-
dc.subjectOncology-
dc.subjectprostate cancer-
dc.subjectPSA nadir-
dc.subjectradical retropubic prostatectomy-
dc.subjectRESOLVED IMMUNOFLUOROMETRIC ASSAY-
dc.subjectRETROPUBIC PROSTATECTOMY-
dc.subjectPATHOLOGICAL FINDINGS-
dc.subjectSURGICAL MARGINS-
dc.subjectANTIGEN-
dc.subjectRECURRENCE-
dc.subjectSERUM-
dc.subjectTIME-
dc.subjectPRESERVATION-
dc.subjectCOMBINATION-
dc.subjectAdult-
dc.subjectAged-
dc.subjectDecision Support Techniques-
dc.subjectDisease-Free Survival-
dc.subjectHumans-
dc.subjectMale-
dc.subjectMiddle Aged-
dc.subjectMultivariate Analysis-
dc.subjectNeoplasm Staging-
dc.subjectPredictive Value of Tests-
dc.subjectProportional Hazards Models-
dc.subjectProstate-Specific Antigen-
dc.subjectProstatectomy-
dc.subjectProstatic Neoplasms-
dc.subjectSalvage Therapy-
dc.subjectSensitivity and Specificity-
dc.subjectHumans-
dc.subjectProstatic Neoplasms-
dc.subjectProstate-Specific Antigen-
dc.subjectNeoplasm Staging-
dc.subjectDisease-Free Survival-
dc.subjectSalvage Therapy-
dc.subjectProstatectomy-
dc.subjectMultivariate Analysis-
dc.subjectProportional Hazards Models-
dc.subjectSensitivity and Specificity-
dc.subjectPredictive Value of Tests-
dc.subjectDecision Support Techniques-
dc.subjectAdult-
dc.subjectAged-
dc.subjectMiddle Aged-
dc.subjectMale-
dc.subjectOncology & Carcinogenesis-
dc.subjectOncology And Carcinogenesis-
dc.titleUndetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival-
dc.typeArticle-
Appears in Collections:Department of Surgery and Cancer

Files in This Item:
Click on the URI links for accessing contents.


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.